The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil

• Hauptverfasser: Antonio V. Alves da Silva (Verfasst von), Francisco Martins Neto (Verfasst von), Ana Claudia da Silva M. de Oliveira (Verfasst von), Benedito A. Carneiro (Verfasst von), Marclesson Alves (Verfasst von), Cleto Dantas Nogueira (Verfasst von), Fabio Tavora (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2019-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract Background As Immune checkpoint inhibitors (ICPIs) are changing the standard-care in lung cancer with good clinical activities and durable responses, its indication must be based on the appropriate patient selection once only a fraction of patients has a response to these costly drugs. In l...